AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Natural History of Injectable Permanent Synthetic Filler Disease

Recruitingn/aAges 18 Years - anyFemaleResearch Inc
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Injectable permanent synthetic filler disease is characterized by heterogeneous local and systemic manifestations that may emerge years after filler injection. Although inflammatory reactions, migration, foreign-body granulomas, adipose tissue injury, fat necrosis, and fibrosis have been individually described, the temporal clinicopathologic evolution of the disease remains poorly characterized. This prospective observational cohort study aims to characterize the natural history of disease associated with injectable permanent synthetic fillers by integrating time since injection, clinical manifestations, magnetic resonance imaging findings, and histopathologic tissue features. Participants with a history of gluteal injection of permanent synthetic fillers who undergo clinical evaluation, magnetic resonance imaging, and clinically indicated surgical removal of affected tissue will be eva

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults with a documented history of injection of permanent synthetic or modeling substances into the gluteal region. Available date or sufficiently reliable estimated date of filler injection to determine disease duration. Prospective clinical assessment documenting local and/or systemic manifestations. Available magnetic resonance imaging of the affected anatomical region performed as part of clinical evaluation. Clinically indicated surgical removal of affected tissue. Histopathologic tissue specimen available and of sufficient quality for standardized review. Availability of the core clinical, radiologic, and histopathologic variables required for the primary analysis. Written informed consent when required by the approved research protocol. Exclusion Criteria: * Exposure exclusively to temporary or resorbable fillers without evidence of permanent synthetic filler exposure. Inability to determine the approximate date of filler injection. Histopathologic specimens insufficient for standardized evaluation. Magnetic resonance imaging unavailable or technically inadequate for assessment of disease distribution. Incomplete core clinical data preventing evaluation of the prespecified study outcomes. Previous complete surgical removal of the injected material before the index clinical and imaging assessment, when this prevents reconstruction of the untreated disease state.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Clinica Bioforma
Medellรญn, Colombia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy